2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301551
The prevalence of anemia in people with chronic kidney disease after hematopoietic stem cell transplantation.
Kępska-Dzilińska M, Karakulska-Prystupiuk E, Kaszyńska A, Basak GW, Małyszko J.
Ren Fail. 2023;45(2):2263581. doi: 10.1080/0886022X.2023.2263581. Epub 2023 Oct 2.
PMID:37782282
Kidney Injury in Children after Hematopoietic Stem Cell Transplant.
James V, Angelo J, Elbahlawan L.
Curr Oncol. 2023 Mar 13;30(3):3329-3343. doi: 10.3390/curroncol30030253.
PMID:36975466
Hematopoietic stem cell transplantation in patients with chronic kidney disease.
Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations.
An Overview of Kidney Disease Following Hematopoietic Cell Transplantation.
Ando M.
Intern Med. 2018 Jun 1;57(11):1503-1508. doi: 10.2169/internalmedicine.9838-17. Epub 2018 Jan 11.
PMID:29321440
Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.
Hingorani S.
J Am Soc Nephrol. 2006 Jul;17(7):1995-2005. doi: 10.1681/ASN.2006020118. Epub 2006 May 24.
PMID:16723390
Chronic kidney disease, survival and graft-versus-host-disease-free/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant.
Pelletier K, Côté G, Madsen K, Chen S, Kim SJ, Chan CT, Mattsson J, Pasic I, Kitchlu A.
Clin Kidney J. 2022 Apr 7;15(8):1583-1592. doi: 10.1093/ckj/sfac091. eCollection 2022 Aug.